Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Apyx Medical Corp Director's Dealing 2013

Aug 14, 2013

34303_dirs_2013-08-14_0c4d081e-2cb2-4928-9f57-b0dba5a8d64e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOVIE MEDICAL CORP (bvx)
CIK: 0000719135
Period of Report: 2013-07-16

Reporting Person: Waldman Lawrence (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-07-16 Stock options $2.97 A 12000 Acquired 2023-07-16 Common stock (12000) Direct

Footnotes

F1: Reporting person was granted a stock option to vest and be exercisable over 3 years at the rate of 33.33% of the option on the anniversary date of each succeeding year and shall become fully vested and fully exercisable on the third anniversary of the date of grant.